Brain Tumor Center Offering Translational Research Grants
The Brain Tumor Center at the University of Cincinnati Neuroscience Institute announces its second Molecular Therapeutics Pilot Grant Program to accelerate basic and translational research of primary and metastatic brain tumors.
All UC faculty with 80% or greater FTE, including those based at Cincinnati Childrens Hospital Medical Center and the Cincinnati VA Medical Center, are eligible to apply.
Interested applicants may submit a Letter of Intent and NIH biosketch to Angel Hall by August 1, 2013. Read additional information in the Request for Proposal.
Questions can be directed to business manager Angel Hall at angel.hall@uchealth.com or 513-558-8646.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.